CRS 34 is set to undock from the ISS on June 16 and splash down off California the next morning, returning thousands of pounds of station built research.
A SpaceX Dragon cargo capsule is set to detach from the International Space Station next Tuesday (June 16), returning to Earth with thousands of pounds of research, including bioprinted tissue that could one day support long-duration space missions, data on storing cryogenic rocket fuel in orbit, and DNA-inspired materials being studied for cancer treatment.
The capsule is the 34th SpaceX Commercial Resupply Services mission to the orbiting laboratory, designated CRS-34, a routine but cargo-dense leg in a program that has been ferrying science to and from the station for more than a decade. Undocking from the station's Harmony module forward port is scheduled for about 12:05 p.m. EDT on June 16, after SpaceX ground controllers send the departure command. NASA plans to begin its live broadcast at 11:45 a.m. EDT on NASA+, Amazon Prime, and YouTube, with coverage details posted in the agency's June 11 release. Splashdown is expected off the California coast on Wednesday, June 17, at approximately 5:08 a.m. PDT. NASA has said it will not stream the splashdown itself; updates will appear on the space station blog.
The returning manifest centers on three research threads.
The first involves bioprinted organ and cartilage tissue samples produced in microgravity. Tissue grown in orbit behaves differently than tissue grown under full Earth gravity, in part because the printing process and the cell culture both proceed without sedimentation, and partly because cells themselves respond to the lack of mechanical loading. Researchers will study the returned samples to refine techniques that could eventually support medical care on long-duration missions, where resupply from the ground is not an option and a crew must rely on what can be grown or manufactured in transit.
The second thread is engineering data from experiments on cryogenic propellant storage. Industry and NASA program documentation widely cite storing fuels such as liquid methane and liquid oxygen in orbit — with minimal boil-off — as a key technical hurdle for any reusable architecture that wants to refuel in space. The Dragon is bringing home measurements from station-based hardware designed to test insulation, fluid behavior, and tank-management approaches. The data feeds directly into the kind of orbital propellant transfer work needed for any future crewed Mars mission that depends on refueling depots in low Earth orbit. Whether the CRS-34 results advance that work, or just contribute one more data point to a multi-flight program, will become clearer in the contractor and peer-reviewed reporting over the coming months.
The third thread is DNA-inspired materials for cancer treatment. Researchers synthesized or processed those materials on the station and are now sending samples back for analysis. The hypothesis is that structural features inspired by DNA can be tuned to interact with cancer cells in specific ways. Independent reporting on outcomes from the returned samples is not yet available, and NASA's framing of the research as promising is the only signal on the public record so far. Naming a principal investigator, a host institution, or a target cancer type will require follow-up sourcing; the current evidence is the manifest entry itself.
Alongside the science, the Dragon is returning three pieces of hardware: an ocular imaging device used to monitor crew eye health during long stays in microgravity, an absorbent bed that filters trace contaminants from the station's cabin air, and a separator pump pulled from the waste and hygiene compartment. Each is being returned for refurbishment, study, or both. Eye health is a documented concern on long missions: fluid shifts in microgravity change the shape of the eyeball, and the station has been collecting imaging data to track that progression across crews.
CRS-34 launched May 15 from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida, docked autonomously to Harmony on May 17 with about 6,500 pounds of crew supplies and science for the station's Expedition 74 crew, according to NASA's prelaunch release. The upward leg also carried a project evaluating how well Earth-based simulators mimic microgravity, a wood-derived bone scaffold for osteoporosis research, a red-blood-cell and spleen study, a charged-particle instrument relevant to power grids and satellites in orbit, a planet-formation investigation, and a sunlight-reflectance instrument called CLARREO-Pathfinder. The list hints at the cadence the station now runs: a steady rotation of small, contained experiments, returning samples, and replaced hardware, all carried by a single commercial partner.
The splashdown profile is the operational wrinkle. West-coast splashdowns, like the one CRS-34 is set to make, have become a more regular feature of Cargo Dragon operations in recent years; earlier returns favored Florida's Atlantic coast. This shift appears to reflect changes in flight profile, deorbit geometry, and recovery planning — though NASA's release does not explain the move, and for now it remains a fact about this flight rather than a documented program change.
Watch items: the undocking time and splashdown will determine whether CRS-34 lands cleanly within its planned window. The science returns, especially the bioprinted tissue and the cryogenic propellant data, will surface in peer-reviewed work and contractor announcements over the coming months. The cancer-materials samples have the longest road to results, since the analysis is back on the ground and the experiments themselves are early-stage. For now, the mission is a textbook commercial resupply leg with a manifest organized around specific, recoverable results, and the coverage window next week is the public's only scheduled look at the handoff.